Clinical trials recruiting for Localized Prostate Carcinoma

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• 24 Gy in One Fraction Urethral-sparing "HDR Like" SBRT for Prostate Cancer
  NCT05936736 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
  NCT05751434 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 10 locations
• Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer
  NCT06389786 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years to 85 Years · Sex: Male · 1 location
• Addressing Health Literacy With a Tailored Survivorship Care Plan
  NCT06674863 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 3 locations
• Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT
  NCT07455903 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617
  NCT07054346 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 1 location
• Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer (SINO-TOP)
  NCT06238713 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: Male · 1 location
• Feasibility and Effect of Wrapping Nerves With a Multi-Layer Perinatal Tissue Allograft During Prostatectomy
  NCT06940271 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years and older · Sex: Male · 1 location
• Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate Cancer
  NCT06178354 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
  NCT06500169 · Phase: Not applicable (e.g. observational or device study) · Ages: 55 Years to 85 Years · Sex: Male · 2 locations
• Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients
  NCT05045066 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: Male · 2 locations
• MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer
  NCT07644598 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer
  NCT06200974 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer
  NCT06834152 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · 3 locations
• PSMA-Guided Ablation of the Prostate
  NCT06003556 · Phase: Phase 2 · Ages: 50 Years and older · Sex: Male · 4 locations
• Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer
  NCT02526368 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: Male · 1 location
• Testing the Effects of Exercise on Colorectal Cancer Development After Treatment With Pelvic Radiation Therapy for Prostate Cancer
  NCT07790718 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 80 Years · Sex: Male · 2 locations
• Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
  NCT06733350 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Male · 1 location
• Two-Fraction Ultrahypofractionated Radiotherapy With Focal Boost for Intermediate Risk, Localized Prostate Cancer
  NCT06518226 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• Two-fraction HDR Monotherapy for Localized Prostate Cancer
  NCT05665738 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost.
  NCT05786742 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 95 Years · Sex: Male · 1 location

Related conditions

Trials recruiting for Localized Prostate Carcinoma often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Localized Prostate Carcinoma trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.